Two years after percutaneous coronary intervention, people at risk of a cardiac event had better outcomes with clopidogrel ...

Urticaria highlights from AAD 2025 include late-breaking results from a phase 1b/2a study of the anti-c-Kit antibody ...

Hidradenitis suppurativa (HS) highlights from AAD 2025 include studies of HS patients' risk for cardiovascular disease or ...

Same-day discharge after joint replacement surgery is feasible in patients with a history of atrial fibrillation (AF), ...

The use of ketamine, midazolam, lorazepam, droperidol, and haloperidol was also assessed. Children who interacted with ...

Implementation of the ERAS program delivers better patient outcomes, achieves shorter lengths of stay, and saves money.

Chewing gum contains plant-based or synthetic plastic polymers, making it a potential source of microplastics; however, the ...

Echocardiography is independently associated with survival time and readmission rates in patients with type 2 diabetes.

The prevalence of cerebral small vessel disease nearly doubled over 7.5 years in neurologically asymptomatic patients with ...

Discussions at the Advanced Technologies & Treatments for Diabetes meeting covered CGM use in non–insulin-treated people with ...

OS for osimertinib vs placebo was 58.8 vs 54 months at the latest analysis of the phase 3 LAURA trial, according to ...

Inotuzumab ozogamicin is safe and effective in adult patients with relapsed/refractory B-cell acute lymphoblastic leukaemia, ...